CannTrust says 'newly uncovered information' from its own special committee's investigation calls into question the validity of its financial statements.
The recent selloff is a great opportunity to buy in, according to Cannabis One's CEO.
Let's see how the charts of GWPH are shaping up.
Shares of Canadian cannabis producer and distributor Cronos rise after the company reports second-quarter earnings that exceed analysts' forecasts amid ongoing demand for its marijuana-infused products.
Greenlane has exclusive U.S. distribution rights for Canopy Growth's Storz & Bickel vaporizers.
AriZona's subsidiary Herbal Enterprises will direct brand and product conceptual design.
Shares of GW Pharmaceuticals surge following soaring sales of its marijuana-derived epilepsy drug that prompts two analysts to raise their stock-price targets.